Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Run-Up Trade: Biodel's Insulin Trial Results
TheStreet.com
Thursday, May 30, 2013 - 9:01am
tags:
insulin, diabetes, Biodel, BIOD-123, MannKind, Afrezza
'Pay-for-Delay' Decision May Not Resolve Issue
Med Page Today
Thursday, May 30, 2013 - 8:59am
tags:
pay-for-delay, Supreme Court
High doses of common painkillers increase heart attack risks
Reuters
Thursday, May 30, 2013 - 8:58am
tags:
ibuprofen, diclofenac, rheumatoid arthritis, NSAIDs, COX-2 inhibitors
Diabetes Drug From Bristol and Astra Wins U.K. Panel’s Backing
Bloomberg
Thursday, May 30, 2013 - 8:56am
tags:
diabetes, Bristol-Myers Squibb, AstraZeneca, UK, Forixga
Bayer Shakes Up Prostate Cancer Market
Motley Fool
Wednesday, May 29, 2013 - 4:50pm
tags:
prostate cancer, Bayer, Xofigo
GlaxoSmithKline gains FDA OK on two genetically targeted skin cancer drugs
Fierce Biotech
Wednesday, May 29, 2013 - 4:49pm
tags:
FDA, GSK, melanoma, dabrafenib, trametinib
Controversial Analysis Of Disputed Trial Finds Avandia Is Safe, After All
Pharmalot
Wednesday, May 29, 2013 - 4:46pm
tags:
GSK, Avandia, diabetes
4 Biotech Stocks Offering Potential, Pipeline And Price
Seeking Alpha
Wednesday, May 29, 2013 - 4:45pm
tags:
Vical, Rockwell Medical, Cytokinetics, Labstyle Innovations
Perrigo seeks approval of generic version of testosterone product Axiron; gets sued by Lilly
Yahoo/AP
Wednesday, May 29, 2013 - 4:43pm
tags:
Perrigo, generics, testosterone, Axiron, Eli Lilly
A Change At The FDA
Forbes
Wednesday, May 29, 2013 - 4:36pm
tags:
FDA, Mary Parks
Biogen Idec's MS Drug Launch Is Going Amazingly Well. These Two Graphs Prove It
Forbes
Wednesday, May 29, 2013 - 4:31pm
tags:
drug launches, MS, multiple sclerosis, Biogen Idec, Tecfidera
Are biotech IPOs already getting too hot to handle?
Fierce Biotech
Wednesday, May 29, 2013 - 9:03am
tags:
biotech, IPOs
Achillion Names New CEO
Motley Fool
Wednesday, May 29, 2013 - 9:01am
tags:
Achillion, Pharma CEOs, Milind Deshpande
UCB agrees sale of U.S. production plant
Reuters
Wednesday, May 29, 2013 - 8:59am
tags:
UCB Pharmaceuticals, UNITHER
Indian Hospital Bans Ranbaxy Drugs As Docs Question Safety
Pharmalot
Wednesday, May 29, 2013 - 8:57am
tags:
Indian, Ranbaxy
Medtronic And Boston Scientific Are In A Race To Build A Better Pain Device
Seeking Alpha
Wednesday, May 29, 2013 - 8:55am
tags:
Medtronic, Boston Scientific, devices, chronic pain
Bayer receives antitrust clearance from FTC for its acquisition of Conceptus
Yahoo/AP
Wednesday, May 29, 2013 - 8:52am
tags:
FTC, Conceptus, devices, Bayer, M&A
Obamacare Will Bring Drug Industry $35 Billion In Profits
Forbes
Wednesday, May 29, 2013 - 8:51am
tags:
Obamacare, Affordable Care Act
POZEN's NDA for PA32540/PA8140 tablets accepted by FDA for review
Yahoo/Fly on the Wall
Wednesday, May 29, 2013 - 8:49am
tags:
Pozen, PA32540, FDA
As Statins Soar, Use Of Other Cholesterol Medicines Declines
Forbes
Wednesday, May 29, 2013 - 8:46am
tags:
statins

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.